Breathe Well Live Well
Lung Disease News |
Allergist's Asthma Work Supported by $1.3M from Research Partners
Lung Disease News The research work of Canadian allergist and asthma researcher Harissios Vliagoftis will be funded through 2020 by $1.3 million in partnership funding from GlaxoSmithKline (GSK), the Canadian Institutes of Health Research (CIHR), and the University of … |
View full post on asthma – Google News
Highly active antiretroviral therapy (HAART), currently known for its therapeutic benefits against HIV, also reduced the spread of the virus among people with a history of injection drug use, according to a population-based study funded by the National Institute on Drug Abuse (NIDA), a component of the National Institutes of Health. The study was published today in the Lancet.
View full post on National Institutes of Health (NIH) News Releases